Page last updated: 2024-09-05

alagebrium and Diabetic Neuropathies

alagebrium has been researched along with Diabetic Neuropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, J1
Cooper, ME; Forbes, JM; Sourris, KC1

Reviews

2 review(s) available for alagebrium and Diabetic Neuropathies

ArticleYear
[Development of therapeutic agents for diabetic neuropathies].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Aldehyde Reductase; Antioxidants; C-Peptide; Diabetic Neuropathies; Drug Design; Enzyme Inhibitors; Genetic Therapy; Glycation End Products, Advanced; Hedgehog Proteins; Humans; Indoles; Maleimides; Nerve Growth Factor; Oxidative Stress; Polymers; Protein Kinase C; Rhodanine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines; Trans-Activators; Vascular Endothelial Growth Factor A

2005
Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?
    Annals of the New York Academy of Sciences, 2008, Volume: 1126

    Topics: Carnosine; Diabetes Complications; Diabetic Neuropathies; Glycation End Products, Advanced; Humans; Reactive Oxygen Species; Thiazoles

2008